Main > ONCOLOGY (**) > Thyroid Cancer *** > Treatment > Co: CH. I. LevoThyroxine Na Oral***



Co: CH. I. LevoThyroxine Na Oral***'s subsections
(*) USA Approval Date: 2017. 02.15
>Liquid
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 12.18.
TradeMark

Co: CH. I. LevoThyroxine Na Oral***'s products
This section has no products